drugset / Trial / NCT02074904
Topiramate's Effects on Heavy Drinking
RandomizedParallel-groupDouble-blindTreatment
Summary
The proposed project will utilize perfusion functional magnetic resonance imaging (fMRI) to examine the effects of topiramate on brain and behavioral responses in heavy drinkers to appetitive alcohol reminders (cues that motivate continued alcohol use and relapse). This project will yield novel findings on brain and behavioral responses to alcohol cues, the effects of topiramate on alcohol cue reactivity, and the mechanisms underlying topiramate's ability to blunt alcohol cue reactivity and heavy drinking.
Timeline
- Start
- 2015-05
- Primary completion
- 2017-03
- Completion
- 2017-03
Outcome
Outcome not reported
Stopped: “We terminated the study to run it as a sub-study of NCT02371889, which is a 13 week, placebo controlled, double-blind, trial of topiramate in heavy drinkers.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 200 mg | Oral |